DUBAI, November 10, 2025 — BioGrowing, a comprehensive probiotic solution provider, attended 2025 GULFOOD Dubai, one of the world’s largest and most influential food and beverage trade shows from November 4 to 7. The company showcased its cutting-edge probiotic innovations, including the new Akkermansia muciniphila Double Star strains, OralBubble™ Probiotic Microbubble Lozenge, and full-chain probiotic solutions, capturing intense attention from industry experts worldwide and injecting new vitality into the booming Middle East probiotic market.
The probiotic supplement market in the Middle East and Africa (MEA) has witnessed robust growth in recent years. Data shows that MEA’s total sales of probiotic supplements reached $116 million in 2023, with a projected compound annual growth rate (CAGR) of 9.4% from 2025 to 2029. This promising market outlook has attracted global probiotic leaders like BioGrowing to deepen their regional presence.
Star Strains: Targeting Metabolic Health Challenges
Against the backdrop of modern lifestyles marked by fast pace and high stress, issues such as gastrointestinal discomfort, slowed metabolism, and blood sugar imbalance have become major health concerns. BioGrowing’s AKK strains (Akkermansia muciniphila) emerged as star products at the show, addressing these critical needs.
AKK WST01 live strain underwent randomized, double-blind, placebo-controlled, multi-center clinical studies. Verified to deliver positive effects on weight management, fat reduction, and blood sugar control, its findings were published in the international authoritative journal Cell Metabolism. AKK WST01 is capable of functionally producing Amuc_1100 and P9 proteins, which induce intestinal L cells to release GLP-1. Acting as a natural GLP-1 secretagogue, it modulates metabolic processes via diverse pathways and has secured patent approvals in 13 countries and regions.
AKKBG-001™ inactivated strain is produced via BioGrowing’s proprietary anaerobic fermentation and high-fidelity inactivation technology. Tests confirm its efficacy in repairing gastrointestinal mucosal damage, boosting energy metabolism, and promoting fat breakdown.
Both strains have achieved large-scale mass production. The AKKBG-001™ Weight Management product exhibited at the show contains 30 billion TFU of high-purity powder per capsule, combined with EGCG green tea extract and vitamins, delivering a more potent approach to weight management.
Another standout, Weizmannia coagulans BC-G44, extracted from naturally fermented yellow peaches, boasts exceptional resistance to acid, alkali, high temperatures, and storage. It maintains 86.85% survival rate after 5 minutes at 140°C dry heat and 96.4% spore survival rate after 2 years of room temperature storage. Clinically proven to support intestinal and immune health, as well as muscle metabolism in sports nutrition, it aligns perfectly with the hot climate and health needs of the Middle East market.
Meanwhile, postbiotic solutions for regions under hot weather include patented strains like Lactiplantibacillus plantarum ZJUF N1 and Lactobacillus plantarum Lp-G18 in postbiotic form, which provide antioxidant, lipid-lowering, and metabolic regulation benefits, while being stable, safe, and suited for snacks, beverages, and dietary supplements.
Innovative Oral Formulations: Merging Efficacy with Convenience
BioGrowing translates laboratory breakthroughs into accessible daily health solutions, with its innovative oral probiotic formulations gaining widespread acclaim.
- OralFlash™ Flash-Melt Probiotics: Featuring ultra-micron particles, this product combines live probiotics (Lactobacillus plantarum Lp-G18, Lactobacillus acidophilus LA-G80, Bifidobacterium infantisBI-G201, Bifidobacterium animalis subsp. lactisBL-G101) with postbiotics (inactivated Lacticaseibacillus paracasei LPc-G110), prebiotics, and natural flavors. It dissolves instantly in the mouth, eliminating clumping, stickiness, or choking issues associated with traditional solid beverages, while enhancing absorption efficiency for immune and intestinal health.
- OralBubble™ Probiotic Microbubble Lozenge:Equipped with three clinically proven strains (Ligilactobacillus salivariusLS-G60, Lacticaseibacillus paracasei LPc-G110, Lactobacillus plantarum Lp-G18) and prebiotics like inulin and isomaltulose, this product forms a comprehensive oral health shield. It addresses 8 common oral problems, including bad breath, gingivitis, tooth decay, and canker sores, with a fresh fruity taste and creamy texture. It attracted Middle Eastern clients to try it onsite and inquire about its cooperation.
Flora-Focus®: Comprehensive Health Solutions for Various Scenarios
Beyond standalone products, BioGrowing presented its Flora-Focus® series, offering 9 targeted probiotic solutions covering gut health, oral health, immunity, weight management, female care, skin health, blood glucose management, blood pressure improvement, and Anti-H. pylori.
Notably, the Flora-Focus® Gut Health solution product, featuring patented strain Lactiplantibacillus plantarum YS1, Bifidobacterium animalis subsp. lactis BL-G101, Lactobacillus acidophilus LA-G80, and Bifidobacterium bifidum BB-G90, received high praise from Middle Eastern clients. Clinically validated to protect gastric mucosa, soften stools, and improve intestinal function, it is suitable for applications in milk powder, meal replacements, and solid beverages. Middle Eastern clients also showed strong interest in other solutions as well as BioGrowing’s capability to customize strain formulations and solutions tailored to specific health needs.
Full-Chain ODM/CDMO Services Backed by Global Certifications
BioGrowing’s strength lies in its integrated R&D and production capabilities. The company holds over 10 international certifications, including ISO22000, FSSC22000, and US FDA approval, with a proprietary strain library of over 50,000 strains. Its product portfolio covers bacterial powder, capsules, probiotic solid beverages, and more, providing one-stop ODM/CDMO support from R&D to production. By now, BioGrowing boasts 70+ patents, 100+ published research papers, and presence in over 80 export countries.
The successful participation in GULFOOD Dubai marks a new step in BioGrowing’s Middle East expansion strategy. This month, BioGrowing also brought its probiotic solutions to the SupplySide Global Expo in Las Vegas, where the company showcased its cutting-edge probiotic technology and forward-looking health philosophy to demonstrate its strength in delivering more personalized, demand-driven cooperation opportunities across the global markets.
BioGrowing will continue to deepen probiotic R&D and production, collaborate with global industry partners, and drive the innovation of the international probiotic industry, adhering to its commitment: “BioGrowing, Reliable for a Better World.”
About BioGrowing
BioGrowing Co., Ltd. is a probiotics comprehensive solution provider focused on the research, development, production and sales of high-quality probiotic products. As one of the largest probiotic production bases in Asia, the company offers a product range covering probiotic powders, starter cultures, functional foods, and derivative products which are widely used in food, medicine and healthcare, daily chemicals, aquaculture, and many other fields. BioGrowing maintains a repository of over 50,000 probiotic strains, each with independent intellectual property rights. The products have been successfully exported to over 80 countries, including 22 out of the 27 EU member nations. With “BioGrowing, Reliable for a Better World” as its core value, BioGrowing is committed to probiotics’ research, development, and innovation, moving continuously towards the vision of a “global leading probiotics manufacturer” and providing customers with a full range of product solutions and high-quality services.
Media Contact
Name: Rena Yuan
Email: cs@biogrowing.com
Website: www.biogrowing.com
